跳至主要内容
临床试验/NCT00387309
NCT00387309已完成3 期

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of Post Operative Ileus.

Bausch Health Americas, Inc.92 个研究点 分布在 1 个国家目标入组 495 人开始时间: 2006年12月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
495
试验地点
92
主要终点
Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the MOA-728 regimen than with a placebo regimen.

研究概览

简要总结

Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the investigational MOA-728 regimen than with a placebo regimen.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the MOA-728 regimen than with a placebo regimen.

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (92)

Loading locations...

相似试验